{"version":"1.0","type":"link","title":"Pirtobrutinib, a highly selective, noncovalent (reversible) BTKi in R/R marginal zone lymphoma: phase 1/2 BRUIN study.","author_name":"Patel K 외","author_url":"https://prs-insight.online/author/Patel%20K","provider_name":"PRSinsight","provider_url":"https://prs-insight.online","thumbnail_url":"https://prs-insight.online/og/paper/158692","thumbnail_width":1200,"thumbnail_height":630}